Great West Life Assurance CO Syndax Pharmaceuticals Inc Transaction History
Great West Life Assurance CO
- $49.6 Billion
- Q1 2024
A detailed history of Great West Life Assurance CO transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Great West Life Assurance CO holds 7,182 shares of SNDX stock, worth $165,760. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,182
Previous 5,595
28.36%
Holding current value
$165,760
Previous $120,000
42.5%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding SNDX
# of Institutions
197Shares Held
90.1MCall Options Held
353KPut Options Held
207K-
Black Rock Inc. New York, NY7.55MShares$174 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA7.44MShares$172 Million0.03% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.66MShares$131 Million14.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.93MShares$114 Million0.0% of portfolio
-
State Street Corp Boston, MA4.82MShares$111 Million0.01% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $1.31B
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...